Trial Methodology in Soft Tissue Sarcomas; The ‘One Plus One Is Three or Zero’ Phenomenon

Onkologie
doi 10.1159/000113414
Full Text
Abstract

Available in full text

Date
Authors
Publisher

S. Karger AG

Related search

A Randomised Phase II Trial of Selumetinib vs Selumetinib Plus Temsirolimus for Soft-Tissue Sarcomas

British Journal of Cancer
Cancer ResearchOncology
2015English

Kinesthetic Aftereffect: One Phenomenon or Two?

Perception & Psychophysics
1986English

One Plus One Equals Three (Or More …): Combining the Assessment of Movement Behavior and Subjective States in Everyday Life

Frontiers in Psychology
Psychology
2013English

Notch Signaling in Pediatric Soft Tissue Sarcomas

BMC Medicine
Medicine
2012English

Chemotherapy in Pediatric-Type Soft-Tissue Sarcomas

Current Oncology
Oncology
2020English

Randomized Comparison of Doxorubicin Alone Versus Ifosfamide Plus Doxorubicin or Mitomycin, Doxorubicin, and Cisplatin Against Advanced Soft Tissue Sarcomas.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
1993English

Pediatric Bone and Soft-Tissue Sarcomas

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2015English

Guidelines for the Management of Soft Tissue Sarcomas

Sarcoma
Nuclear MedicineRadiologyImagingOncology
2010English

Vascular Reconstruction in the Resection of Soft Tissue Sarcomas

Perspectives in Vascular Surgery
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy